UNITED THERAPEUTICS CORP (UTHR)
EDGEMOND JAMES 🟡 adjusted position in 10.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $571.65 ($8.3M) Transaction Date: Apr 02, 2026 | Filing ID: 000006
EDGEMOND JAMES 🟡 adjusted position in 10.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $571.65 ($8.3M) Transaction Date: Apr 02, 2026 | Filing ID: 000006
🔍 EDGEMOND JAMES (Executive)
Company: UNITED THERAPEUTICS Corp (UTHR)
Report Date: 2026-04-02
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-04-02 | Code: M | equity_swap_involved: false | shares_owned_after: 28,876.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 28,836.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 28,435.00 | transaction_form_type: 4 | Footnotes: F1, F3
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 27,657.00 | transaction_form_type: 4 | Footnotes: F1, F4
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 26,813.00 | transaction_form_type: 4 | Footnotes: F1, F5
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 25,836.00 | transaction_form_type: 4 | Footnotes: F1, F6
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 25,116.00 | transaction_form_type: 4 | Footnotes: F1, F7
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 24,876.00 | transaction_form_type: 4 | Footnotes: F1, F8
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 24,804.00 | transaction_form_type: 4 | Footnotes: F1, F9
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 24,233.00 | transaction_form_type: 4 | Footnotes: F1, F10
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 23,678.00 | transaction_form_type: 4 | Footnotes: F1, F11
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 22,782.00 | transaction_form_type: 4 | Footnotes: F1, F12
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 20,581.00 | transaction_form_type: 4 | Footnotes: F1, F13
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 19,839.00 | transaction_form_type: 4 | Footnotes: F1, F14
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 19,516.00 | transaction_form_type: 4 | Footnotes: F1, F15
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 19,116.00 | transaction_form_type: 4 | Footnotes: F1, F16
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 18,996.00 | transaction_form_type: 4 | Footnotes: F1, F17
Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 18,876.00 | transaction_form_type: 4 | Footnotes: F1, F18
Date: 2026-04-02 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 122,500.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes: